These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 53917)

  • 1. Hydroxyethyl starch as an experimental adjunct to leukocyte separation by centrifugal means: review of safety and efficacy.
    Mishler JM
    Transfusion; 1975; 15(5):449-60. PubMed ID: 53917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new method to collect granulocytes using a low dose of hydroxyethyl starch.
    Szymanski IO
    Vox Sang; 1983; 44(2):106-14. PubMed ID: 6187130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harvesting of granulocytes using a hydroxyethyl starch solution.
    Sussman LN; Colli W; Pichetshote C
    Transfusion; 1975; 15(5):461-5. PubMed ID: 53918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a practical oral dexamethasone premedication schedule leading to improved granulocyte yields with the continuous-flow centrifugal blood cell separator.
    Winton EF; Vogler WR
    Blood; 1978 Jul; 52(1):249-53. PubMed ID: 77695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of dexamethasone and hydroxyethyl starch in the multiply leukapheresed donor.
    Mishler JM; Moser AM; Carter JB
    Transfusion; 1976; 16(2):170-3. PubMed ID: 56793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro comparison of the erythrocyte sedimenting properties of dextran, hydroxyethyl starch and a new low-molecular-weight hydroxyethyl starch.
    Strauss RG
    Vox Sang; 1979; 37(5):268-71. PubMed ID: 93347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of leucocyte-poor red blood cell suspensions prepared by sedimentation in hydroxyethyl starch.
    Dorner I; Moore JA; Collins JA; Sherman LA; Chaplin H
    Transfusion; 1975; 15(5):439-48. PubMed ID: 53916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyethyl starch and prednisone as adjuncts to granulocyte collection.
    Bearden JD; Coltman CA; Ratkin GA
    Transfusion; 1977; 17(2):141-6. PubMed ID: 66779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter trial to document the efficacy and safety of a rapidly excreted analog of hydroxyethyl starch for leukapheresis with a note on steroid stimulation of granulocyte donors.
    Strauss RG; Hester JP; Vogler WR; Higby DJ; Snikeris AC; Imig KM; Greazel C; Mallard G; Burnett D; Gupta S
    Transfusion; 1986; 26(3):258-64. PubMed ID: 2422795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of hydroxyethyl starch on in vitro platelet and granulocyte function.
    Schiffer CA; Aisner J; Schmukler M; Whitaker CL; Wolff JH
    Transfusion; 1975; 15(5):473-5. PubMed ID: 53920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on immunity of multiple leukapheresis using a rapidly excreted analog of hydroxyethyl starch.
    Strauss RG; Goeken JA; Imig KM; Greazel C
    Transfusion; 1986; 26(3):265-8. PubMed ID: 2422796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on low-dose hydroxyethyl starch leukapheresis. Rate of elimination of HES in vivo and function of the harvested granulocytes in vitro.
    Szymanski IO; Teno RA; Gandhi JG; Newburger PE
    Vox Sang; 1984; 47(5):325-9. PubMed ID: 6209854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hydroxyethyl starch on platelet function following granulocyte collection using the continuous flow cell separator.
    Farrales FB; Belcher C; Summers T; Bayer WL
    Transfusion; 1977; 17(6):635-7. PubMed ID: 74111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The plasma kinetics of hydroxyethyl starch 350/0.60: a potential new adjunct for centrifugal leucapheresis.
    Mishler JM
    Am J Hematol; 1979; 7(4):341-7. PubMed ID: 94771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of hydroxyethyl starch to improve granulocyte collection in the Latham blood processor.
    Huestis DW; White RF; Price MJ; Inman M
    Transfusion; 1975; 15(6):559-64. PubMed ID: 53922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey on the current use of leukapheresis and the collection of granulocyte concentrates.
    French JE; Solomon JM; Fratantoni JC
    Transfusion; 1982; 22(3):220-5. PubMed ID: 6178191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of thymic-derived lymphocytes during pheresis procedures.
    Dwyer JM; Wade MJ; Katz AJ
    Vox Sang; 1981; 41(5-6):287-94. PubMed ID: 6172901
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydroxyethyl starch and dexamethasone as an adjunct to leukocyte separation with the IBM blood cell separator.
    Mishler JM; Higby DJ; Rhomberg W; Cohen E; Nicora RW; Holland JF
    Transfusion; 1974; 14(4):352-6. PubMed ID: 4526417
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to chronic leukapheresis procedures and survival of chronic myelogenous leukemia patients.
    Hester JP; McCredie KB; Freireich EJ
    Transfusion; 1982; 22(4):305-7. PubMed ID: 6179267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukapheresis of patients with chronic granulocytic leukemia (CGL), using the Haemonetics blood processor.
    Huestis DW; Price MJ; White RF; Inman M
    Transfusion; 1976; 16(3):255-60. PubMed ID: 59435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.